Thomas J. Raedler

3.4k total citations · 2 hit papers
46 papers, 2.5k citations indexed

About

Thomas J. Raedler is a scholar working on Psychiatry and Mental health, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas J. Raedler has authored 46 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 13 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas J. Raedler's work include Schizophrenia research and treatment (22 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Thomas J. Raedler is often cited by papers focused on Schizophrenia research and treatment (22 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Thomas J. Raedler collaborates with scholars based in Germany, Canada and United States. Thomas J. Raedler's co-authors include Christian Büchel, Jan Gläscher, Iver Hand, Michael B. Knable, Michael Rose, J.H. Reuter, Daniel R. Weinberger, Klaus Wiedemann, Donald Addington and Rajiv Tandon and has published in prestigious journals such as Nature Neuroscience, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Thomas J. Raedler

45 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathological gambling is linked to reduced activation of the mesolimbic reward system

2005 507 citations Thomas J. Raedler et al. profile →
Guidelines for the Pharmacotherapy of Schizophrenia in Adults

2017 213 citations Thomas J. Raedler et al. profile →

Peers

Countries citing papers authored by Thomas J. Raedler

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Raedler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Raedler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Raedler more than expected).

Fields of papers citing papers by Thomas J. Raedler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Raedler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Raedler. The network helps show where Thomas J. Raedler may publish in the future.

Co-authorship network of co-authors of Thomas J. Raedler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Raedler. A scholar is included among the top collaborators of Thomas J. Raedler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Raedler. Thomas J. Raedler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	No Effects of Antidepressants on Negative Symptoms in Schizophrenia 2013 ·Journal of Clinical Psychopharmacology ·Kim Hinkelmann, Alexander Yassouridis, Michael Kellner, Holger Jahn, Klaus Wiedemann, Thomas J. Raedler	21
2	Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis 2012 ·Epidemiology and Psychiatric Sciences ·Jean Addington, (unknown), (unknown), Thomas J. Raedler	9
3	Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers 2011 ·PLoS ONE ·Holger Jahn, Stefan Wittke, Petra Zürbig, Thomas J. Raedler, Sönke Arlt, Markus Kellmann, William Mullen, Martin Eichenlaub, Harald Mischak, Klaus Wiedemann	95
4	Inflammatory mechanisms in major depressive disorder 2011 ·Current Opinion in Psychiatry ·Thomas J. Raedler	185
5	Cardiovascular aspects of antipsychotics 2010 ·Current Opinion in Psychiatry ·Thomas J. Raedler	72
6	Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results 2007 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Thomas J. Raedler, Stefan Wittke, Holger Jahn, (unknown), Harald Mischak, Klaus Wiedemann	2
7	Dose-dependent constipation with higher doses of quetiapine: a case series 2007 ·International Clinical Psychopharmacology ·Thomas J. Raedler, Jens Reimer, Klaus Wiedemann	12
8	Early onset of treatment effects with oral risperidone 2007 ·BMC Psychiatry ·Thomas J. Raedler, A. Schreiner, Dieter Naber, Klaus Wiedemann	14
9	Megestrol attenuates the hormonal response to CCK-4–induced panic attacks 2006 ·Depression and Anxiety ·Thomas J. Raedler, Holger Jahn, (unknown), Dorothee Maria Gescher, Michael Kellner, Klaus Wiedemann	3
10	Towards a muscarinic hypothesis of schizophrenia 2006 ·Molecular Psychiatry ·Thomas J. Raedler, Frank P. Bymaster, Rajiv Tandon, David Copolov, Brian Dean	227
11	Cholinergic mechanisms in schizophrenia: Current concepts 2006 ·Thomas J. Raedler, Rajiv Tandon	10
12	Gender-Specific Effects in the Treatment of Acute Schizophrenia with Risperidone 2006 ·Pharmacopsychiatry ·Thomas J. Raedler, A. Schreiner, Dieter Naber, Klaus Wiedemann	9
13	The Face of Pain ‐ A Pilot Study to Validate the Measurement of Facial Pain Expression with an Improved EMG Method 2005 ·Pain Research and Management ·Karsten D. Wolf, Thomas J. Raedler, (unknown), Falk Kiefer, Reinhard Maß, Markus Quante, Klaus Wiedemann	27
14	Acute effects of megestrol on the hypothalamic?pituitary?adrenal axis 2003 ·Cancer Chemotherapy and Pharmacology ·Thomas J. Raedler, Holger Jahn, (unknown), Dorothee Maria Gescher, Michael Kellner, Klaus Wiedemann	8
15	Central Muscarinic Acetylcholine Receptor Availability in Patients Treated with Clozapine 2003 ·Neuropsychopharmacology ·Thomas J. Raedler, Michael B. Knable, Douglas W. Jones, (unknown), Michael Egan, Daniel R. Weinberger	36
16	P300 and Genetic Risk for Schizophrenia 2003 ·Archives of General Psychiatry ·Georg Winterer, Michael Egan, Thomas J. Raedler, Carmen E. Sanchez, Douglas W. Jones, Richard Coppola, Daniel R. Weinberger	91
17	In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia 2002 ·American Journal of Psychiatry ·Thomas J. Raedler, Michael B. Knable, Douglas W. Jones, (unknown), Julia G. Gorey, (unknown), Michael Egan, Richard Coppola, Daniel R. Weinberger	179
18	Neuropharmacological studies with spect in neuropsychiatric disorders 2000 ·Nuclear Medicine and Biology ·Andreas Heinz, Douglas W. Jones, Thomas J. Raedler, Richard Coppola, (unknown), Daniel R. Weinberger	16
19	In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine 1999 ·Psychiatry Research Neuroimaging ·Thomas J. Raedler	31
20	Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels 1997 ·Psychiatry Research Neuroimaging ·Michael B. Knable, Andreas Heinz, Thomas J. Raedler, Daniel R. Weinberger	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact